Choosing between possible lives: legal and ethical issues in preimplantation genetic diagnosis.
This article critically appraises the current legal scope of the principal applications of preimplantation genetic diagnosis (PGD). This relatively new technique, which is available to some parents undergoing in vitro fertilization (IVF) treatment, aims to ensure that a child is not born with a seemingly undesirable genetic condition. The question addressed here is whether there should be serious reasons to test for genetic conditions in embryos in order to be able to select between them. The Human Fertilisation and Embryology Authority and the Human Genetics Commission have decided that there should be such reasons by broadly aligning the criteria for PGD with those for selective abortion. This stance is critically explored, as are its implications for the possible use of PGD to select either against or for marginal features or for significant traits. The government is currently reviewing the legal scope and regulation of PGD.
Scott
Rosamund
R
School of Law and Centre of Medical Law and Ethics, King's College London, UK.
D000025:Abortion, Eugenic / Q000941:ethics / Q000331:legislation & jurisprudence; D026683:Advisory Committees; D002648:Child; D002755:Choice Behavior / Q000941:ethics*; D006233:Persons with Disabilities; D004622:Embryo, Mammalian; D026689:Ethical Analysis; D005053:Eugenics; D005260:Female; D005333:Fetus; D030342:Genetic Diseases, Inborn / Q000517:prevention & control; D005820:Genetic Testing / Q000941:ethics; D006801:Humans; D009042:Motivation; D011247:Pregnancy; D019836:Preimplantation Diagnosis / Q000941:ethics*; D011640:Public Policy; D011788:Quality of Life; D006113:United Kingdom; D026712:Value of Life